Recap: ADMA Biologics Q4 Earnings

ADMA Biologics ADMA reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

ADMA Biologics beat estimated earnings by 100.0%, reporting an EPS of $0.04 versus an estimate of $0.02.

Revenue was up $23.92 million from the same period last year.

Last quarter the company beat on EPS by $0.02 which was followed by a 6.0% increase in the share price the next day.

Here's a look at ADMA Biologics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.01	-0.02	-0.04	-0.06
EPS Actual	0.01	-0.03	-0.03	-0.06
Revenue Estimate	62.12M	55.50M	53.41M	45.93M
Revenue Actual	67.28M	60.12M	56.91M	49.98M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar